MXNL04000084A - Forma novedosa de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina. - Google Patents

Forma novedosa de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina.

Info

Publication number
MXNL04000084A
MXNL04000084A MXNL04000084A MXNL04000084A MXNL04000084A MX NL04000084 A MXNL04000084 A MX NL04000084A MX NL04000084 A MXNL04000084 A MX NL04000084A MX NL04000084 A MXNL04000084 A MX NL04000084A MX NL04000084 A MXNL04000084 A MX NL04000084A
Authority
MX
Mexico
Prior art keywords
isopropylcyclohexylcarbonyl
phenylalanine
trans
novel form
compound
Prior art date
Application number
MXNL04000084A
Other languages
English (en)
Spanish (es)
Inventor
Tom Thomas Puthiaparampil
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of MXNL04000084A publication Critical patent/MXNL04000084A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/57Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXNL04000084A 2002-04-29 2002-04-29 Forma novedosa de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina. MXNL04000084A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000114 WO2003093222A1 (en) 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Publications (1)

Publication Number Publication Date
MXNL04000084A true MXNL04000084A (es) 2006-02-28

Family

ID=29287383

Family Applications (1)

Application Number Title Priority Date Filing Date
MXNL04000084A MXNL04000084A (es) 2002-04-29 2002-04-29 Forma novedosa de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina.

Country Status (13)

Country Link
US (1) US7314955B2 (enExample)
EP (1) EP1499586A4 (enExample)
JP (1) JP4137053B2 (enExample)
KR (1) KR20040111490A (enExample)
AU (1) AU2002304281A1 (enExample)
CA (1) CA2481322A1 (enExample)
CZ (1) CZ2004997A3 (enExample)
HR (1) HRP20040920A2 (enExample)
HU (1) HUP0500259A2 (enExample)
IL (1) IL164327A0 (enExample)
MX (1) MXNL04000084A (enExample)
SK (1) SK287644B6 (enExample)
WO (1) WO2003093222A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
WO2004020396A1 (en) * 2002-08-28 2004-03-11 Dr. Reddy's Laboratories Limited Crystalline form of nateglinide and process for preparation thereof
WO2004074330A1 (ja) * 2003-02-18 2004-09-02 Konishi Co., Ltd. 硬化性樹脂、その製造方法及び硬化性樹脂組成物
HU227073B1 (hu) * 2003-07-10 2010-06-28 Richter Gedeon Nyrt Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata
US20070231393A1 (en) * 2004-05-19 2007-10-04 University Of South Carolina System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
GB0413084D0 (en) * 2004-06-11 2004-07-14 Cipla Ltd Process
US20100004334A1 (en) * 2008-07-01 2010-01-07 Mead Johnson Nutrition Company Nutritional Compositions Containing Punicalagins
US11390830B2 (en) 2018-10-05 2022-07-19 The Chemours Company Fc, Llc Compositions comprising 1,2-dichloro-1,2-difluoroethylene for use in cleaning and solvent applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US4814684A (en) * 1987-09-30 1989-03-21 Trw Inc. Apparatus for extending the Vout/Vin ratio of a DC-to-DC converter
EP0526171B1 (en) * 1991-07-30 1997-03-05 Ajinomoto Co., Inc. Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu

Also Published As

Publication number Publication date
SK50052004A3 (sk) 2005-03-04
WO2003093222A1 (en) 2003-11-13
EP1499586A1 (en) 2005-01-26
KR20040111490A (ko) 2004-12-31
US20050165108A1 (en) 2005-07-28
HUP0500259A2 (hu) 2005-06-28
IL164327A0 (en) 2005-12-18
EP1499586A4 (en) 2006-01-18
JP2005523933A (ja) 2005-08-11
JP4137053B2 (ja) 2008-08-20
HRP20040920A2 (en) 2005-02-28
SK287644B6 (sk) 2011-05-06
CZ2004997A3 (cs) 2005-01-12
AU2002304281A1 (en) 2003-11-17
CA2481322A1 (en) 2003-11-13
US7314955B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
MXNL04000084A (es) Forma novedosa de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina.
MXPA02009482A (es) Compuestos tetraciclinas sustituidos con grupos 7- y 9- carbamato, urea, tiourea, tiocarbamato y heteroaril-amino.
GB0305704D0 (en) Radiofluorination methods
TW200602322A (en) Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
GEP20074215B (en) Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof
GEP20105036B (en) Perindopril
TW200603823A (en) Novel use of peptide compounds for treating essential tremor and other tremor syndromes
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
AU2003290592A1 (en) Antitumor benzoylsulfonamides
TW200621752A (en) Pyrimidinylpyrazoles and methods of making and using the same
EE05428B1 (et) Protsess ülipuhta perindopriili ja sünteesi kasulike vaheühendite valmistamiseks
WO2005007124A3 (en) Substituted dihydropyrimidine inhibitors of calcium channel function
MY143266A (en) New process for synthesizing (7-methoxy-3,4-dihydro-1-naphthalenyl)acetonitrile and its application in the synthesis of agomelatine
IL159718A0 (en) Synthesis of intermediates for preparation of stating derivatives
ATE451103T1 (de) Zusammensetzung zur behandlung von atherosklerose,die candesartan und rosuvastatin enthält
EA200501925A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200501900A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
EA200600898A1 (ru) Новый способ синтеза периндоприла и его фармацевтически приемлемых солей
MXPA03008946A (es) Metodos para sintetizar compuestos que contienen fenol.
BR0214445A (pt) Processos para produzir compostos e composto
TW200510276A (en) Calcilytic compounds
NO20060767L (no) Fremgangsmate for syntese av 6-amino-4-(3-klor-4-fluor-fenylamino)-7-etoksykinolin-3-karbonitiril
WO2004052298A3 (en) Narcistatin prodrugs

Legal Events

Date Code Title Description
FA Abandonment or withdrawal